Jiehui Deng

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 15 papers. Top paper: “Targeting HER2 Exon 20 Insertion–Mutant Lung Adenocarcinoma with a Novel Tyrosine Kinase Inhibitor Mobocertinib”.

Targeting HER2 Exon 20 Insertion–Mutant Lung Adenocarcinoma with a Novel Tyrosine Kinase Inhibitor Mobocertinib

Cancer Research(2021)10.1158/0008-5472.can-21-1526

N/A

1.9DataRank · unranked

57 citations

Shuai Li, Ting Chen, Michael Fitzgerald, Shengwu Liu, Chengwei Peng +24 more

Assessing Therapeutic Efficacy of MEK Inhibition in a KRASG12C-Driven Mouse Model of Lung Cancer

Clinical Cancer Research(2018)10.1158/1078-0432.ccr-17-3438

N/A

0.633DataRank · unranked

67 citations

Shengwu Liu, Jiehui Deng, Esra A. Akbay, Josephine Hai, Chiara Ambrogio +22 more

Targeting the Atf7ip–Setdb1 Complex Augments Antitumor Immunity by Boosting Tumor Immunogenicity

Cancer Immunology Research(2021)10.1158/2326-6066.cir-21-0543

N/A

0.557DataRank · unranked

40 citations

Alireza Khodadadi‐Jamayran, Igor Dolgalev, Hyunwoo Cho, Sana Badri, Luis Chiriboga +28 more

Epigenetic CRISPR Screens Identify Npm1 as a Therapeutic Vulnerability in Non–Small Cell Lung Cancer

Cancer Research(2020)10.1158/0008-5472.can-19-3782

N/A

0.515DataRank · unranked

30 citations

Wai‐Lung Ng, Troy A. Luster, Hai Hu, Vladislav O. Sviderskiy, Catríona M. Dowling +25 more

Histone Deacetylase 6 Inhibition Exploits Selective Metabolic Vulnerabilities in LKB1 Mutant, KRAS Driven NSCLC

Journal of Thoracic Oncology(2023)10.1016/j.jtho.2023.03.014

N/A

0.385DataRank · unranked

12 citations

Christopher S. Nabel, Dezhi Li, Ruth Í. O’Connor, Caroline R. Crosby, Sarah Chang +27 more

A Phase 1/2 multicenter trial of DKN-01 as monotherapy or in combination with docetaxel for the treatment of metastatic castration-resistant prostate cancer (mCRPC)

Prostate Cancer and Prostatic Diseases(2024)10.1038/s41391-024-00798-z

N/A

0.345DataRank · unranked

9 citations

Russell K. Pachynski, Samuel R. Denmeade, Rahul Aggarwal, Jiehui Deng, Victor Adorno Febles +27 more

A Multivalent Peptoid Conjugate Modulates Androgen Receptor Transcriptional Activity to Inhibit Therapy-resistant Prostate Cancer

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-23-0196

N/A

0.274DataRank · unranked

4 citations

Jeffrey A. Schneider, Susan Ha, Rachel Ruoff, Luiza Doro Pereira, Joseph Puccini +13 more

TNG260 Is a Small-Molecule CoREST Inhibitor That Sensitizes STK11 -Mutant Tumors to Anti–PD-1 Immunotherapy

Cancer Research(2025)10.1158/0008-5472.can-25-0998

N/A

0.241DataRank · unranked

4 citations

Soumyadip Sahu, Minjie Zhang, Ayushi S. Patel, Ke Geng, Reshmee Bhattacharya +47 more

In vivo metabolomics identifies CD38 as an emergent vulnerability in LKB1 -mutant lung cancer

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.04.18.537350

N/A

0.104DataRank · unranked

1 citations

David H. Peng, David Fenyö, Hao Yuan, Alfonso Lopez, Daniel Levin +26 more

Data from Targeting STAT3 in Adoptively Transferred T Cells Promotes Their In Vivo Expansion and Antitumor Effects

(2023)10.1158/0008-5472.c.6500855

N/A

0DataRank · unranked

0 citations

Chunyan Zhang, Andreas Herrmann, Karen L. Reckamp, Anna Scuto, Michael C. Jensen +5 more

Data from Targeting STAT3 in Adoptively Transferred T Cells Promotes Their In Vivo Expansion and Antitumor Effects

(2023)10.1158/0008-5472.c.6500855.v1

N/A

0DataRank · unranked

0 citations

Chunyan Zhang, Andreas Herrmann, Karen L. Reckamp, Anna Scuto, Michael C. Jensen +5 more

DNA Methylation Profiling Identifies Subgroups of Lung Adenocarcinoma with Distinct Immune Cell Composition, DNA Methylation Age, and Clinical Outcome

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-0391

N/A

0DataRank · unranked

31 citations

Varshini Vasudevaraja, Kristen Labbe, Hussein Mohamed, Jonathan Serrano, Brett W. Guidry +12 more

Targeting DNA Polymerase Epsilon Leads to Tumor Clearance and Activation of an NF-κB-mediated inflammatory response in Triple Negative Breast Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.09.18.677147

N/A

0DataRank · unranked

0 citations

Kenji M. Fujihara, Anthony Tao, Diana Erenburg, Vladislav O. Sviderskiy, Hannan Mir +6 more

Design and Development of DNA Damage Chemical Inducers of Proximity (DD-CIP) for Targeted Cancer Therapy

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.11.03.686423

N/A

0DataRank · unranked

0 citations

Yeuan Ting Lee, Brendan G. Dwyer, Yi Jer Tan, Ting Chen, Belén Romero +8 more

SHP2 inhibition diminishes KRASG12C cycling and promotes tumor microenvironment remodeling

The Journal of Experimental Medicine(2020)10.1084/jem.20201414

N/A

0DataRank · unranked

259 citations

Shuai Li, Kai Wen Teng, Connor Foster, David H. Peng, Hao Ran +18 more